← Back to patent-cliff list
CAS 927961-17-9
methyl 4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl)butanoate
Codes: IVA-337-005
Application context (from source-drug indications)
Non-alcoholic steatohepatitisLanifibranorType 2 diabetesLanifibranor弥漫性硬皮病Lanifibranor
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lanifibranor | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-chloro-2-iodoaniline→benzo[d]thiazole-6-sulfonyl chloride→N-(4-chloro-2-iodophenyl)benzo[d]thiazole-6-sulfonamide→methyl hex-5-ynoate→methyl 4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl)butanoate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | 1,3-BENZOTHIAZOLE-6-SULFONYL CHLORIDE Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.